23andMe, Regeneron and Biotechnology
Digest more
Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key trials expected by 2025-2026.
3h
The Business & Financial Times on MSNGhana needs bold thinkers to achieve food security – OFAB GhanaBy Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering dialogue on agricultural biotechnology to enhance food security and economic growth across the country has encouraged students to choose courses in relation to biotechnology as a panacea to help achieve food security in our country.
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This year's event has significantly expanded its scope, offering an even richer array of content,
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosisNIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders,
Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy.
Explore more
The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school students. The program was launched last year after high school students from Reno who attended the 2024 Biotechnology Symposium expressed interest in a biotechnology immersion opportunity.
Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme they found in bacteria into an efficient, programmable editor of human DNA.
Stellenbosch University (SU) has announced the opening of the LaunchLab CERIBIO, a biotechnology laboratory for biotechnology startups. The initiative aims to accelerate the local biotechnology sector,
Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy protection in a $256 million deal.